Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 130
Filtrer
1.
Genes Brain Behav ; 9(8): 899-909, 2010 Nov.
Article de Anglais | MEDLINE | ID: mdl-20662939

RÉSUMÉ

Fast excitatory transmission in the mammalian central nervous system is mediated by AMPA-type glutamate receptors. The tetrameric AMPA receptor complexes are composed of four subunits, GluR1-4. The GluR4 subunit is highly expressed in the cerebellum and the early postnatal hippocampus and is thought to be involved in synaptic plasticity and the development of functional neural circuitry through the recruitment of other AMPA receptor subunits. Previously, we reported an association of the human GluR4 gene (GRIA4) with schizophrenia. To examine the role of the GluR4 subunit in the higher brain function, we generated GluR4 knockout mice and conducted electrophysiological and behavioural analyses. The mutant mice showed normal long-term potentiation (LTP) in the CA1 region of the hippocampus. The GluR4 knockout mice showed mildly improved spatial working memory in the T-maze test. Although the retention of spatial reference memory was intact in the mutant mice, the acquisition of spatial reference memory was impaired in the Barnes circular maze test. The GluR4 knockout mice showed impaired prepulse inhibition. These results suggest the involvement of the GluR4 subunit in cognitive function.


Sujet(s)
Région CA1 de l'hippocampe/métabolisme , Potentialisation à long terme/génétique , Apprentissage du labyrinthe/physiologie , Inhibition nerveuse/génétique , Récepteur de l'AMPA/génétique , Stimulation acoustique , Animaux , Région CA1 de l'hippocampe/effets des médicaments et des substances chimiques , Conditionnement classique/effets des médicaments et des substances chimiques , Conditionnement classique/physiologie , Maléate de dizocilpine/pharmacologie , Antagonistes des acides aminés excitateurs/pharmacologie , Femelle , Techniques in vitro , Inhibition psychologique , Potentialisation à long terme/physiologie , Mâle , Apprentissage du labyrinthe/effets des médicaments et des substances chimiques , Souris , Souris de lignée C57BL , Souris knockout , Inhibition nerveuse/effets des médicaments et des substances chimiques , Inhibition nerveuse/physiologie , Temps de réaction/effets des médicaments et des substances chimiques , Temps de réaction/génétique , Temps de réaction/physiologie , Récepteur de l'AMPA/antagonistes et inhibiteurs , Récepteur de l'AMPA/métabolisme , Réflexe de sursaut/effets des médicaments et des substances chimiques , Réflexe de sursaut/génétique , Réflexe de sursaut/physiologie , Filtrage sensoriel/effets des médicaments et des substances chimiques , Filtrage sensoriel/génétique , Filtrage sensoriel/physiologie
2.
J Med Genet ; 45(1): 32-5, 2008 Jan.
Article de Anglais | MEDLINE | ID: mdl-17932120

RÉSUMÉ

We have previously mapped autosomal dominant spinocerebellar ataxia (SCA) 16 to 3p26, overlapping with the locus of SCA15. Recently, partial deletions of ITPR1 and the neighbouring SUMF1 in the SCA15 and two additional families were reported. In the present study we determined the copy number of these genes by real time quantitative polymerase chain reaction (PCR) and found a heterozygous deletion of exons 1-48 of ITPR1, but not SUMF1 in SCA16. Breakpoint analysis revealed that the size of the deletion is 313,318 bp and the telomeric breakpoint is located in the middle of their intergenic region. Our data provide evidence that haploinsufficiency of ITPR1 alone causes SCA16 and SCA15.


Sujet(s)
Hétérozygote , Récepteurs à l'inositol 1,4,5-triphosphate/génétique , Délétion de séquence , Ataxies spinocérébelleuses/génétique , Séquence nucléotidique , Exons/génétique , Dosage génique , Humains , Données de séquences moléculaires , Oxidoreductases acting on sulfur group donors , Pedigree , Réaction de polymérisation en chaîne , Sulfuric ester hydrolases/génétique
3.
Ann Trop Med Parasitol ; 101(2): 113-22, 2007 Mar.
Article de Anglais | MEDLINE | ID: mdl-17316497

RÉSUMÉ

Among four ethnic groups in a lowland area of Nepal, the prevalences of abnormal haemoglobin, thalassaemia, glucose-6-phosphate-dehydrogenase (G6PD) deficiency, hereditary South-east Asian ovalocytosis (SAO) and Duffy blood-group antigen Fy/Fy were determined and related to each group's habitat. The group that has lived for many decades in a malaria-endemic lowland area, the Danuwar, was found to have a high prevalence of alpha+-thalassaemia (79.4%) and low prevalences of haemoglobin E and G6PD deficiency. Much lower prevalences of alpha+-thalassaemia were observed in the Newar (20.5%), Parbate (16.5%) and Tamang (8.8%), who, until the 1950s, all spent their hot-season nights in malaria-free areas at higher altitudes. No subjects with any other identified abnormal haemoglobin, beta-thalassaemia, SAO or Fy/Fy were detected.


Sujet(s)
Érythrocytes , Paludisme/épidémiologie , Thalassémie/épidémiologie , Femelle , Humains , Paludisme/génétique , Mâle , Népal/épidémiologie , Thalassémie/génétique
4.
Neurology ; 67(7): 1236-41, 2006 Oct 10.
Article de Anglais | MEDLINE | ID: mdl-17030759

RÉSUMÉ

OBJECTIVE: To identify of the gene responsible for the onset of spinocerebellar ataxia type 16 (SCA16). METHODS: We reanalyzed the linkage of the original Japanese pedigree using updated information, including three additional subjects. We then screened all exons located in the critical region. RESULTS: We reassigned the locus of SCA16 to 3p26.2-pter (maximum logarithm-of-odds score = 5.177) and identified only one point mutation (4,256C-->T) in the 3' untranslated region of the contactin 4 gene (CNTN4) on chromosome 3p26.2-26.3, which cosegregated with the disease. This mutation was not detected in 520 control subjects; moreover, we revised the phenotype of SCA16 from pure to complicated SCA. CONCLUSION: The contactin 4 gene (CNTN4) is associated with cerebellar degeneration in spinocerebellar ataxia type 16. Additional studies are necessary to prove 4,256C-->T to be a causative mutation.


Sujet(s)
Molécules d'adhérence cellulaire neuronale/génétique , Cartographie chromosomique , Chromosomes humains de la paire 3/génétique , Prédisposition génétique à une maladie/génétique , Dépistage génétique/méthodes , Déséquilibre de liaison/génétique , Ataxies spinocérébelleuses/génétique , Contactines , Analyse de mutations d'ADN , Femelle , Hétérozygote , Humains , Japon , Mâle , Pedigree
5.
Psychiatr Genet ; 11(3): 139-44, 2001 Sep.
Article de Anglais | MEDLINE | ID: mdl-11702055

RÉSUMÉ

The glutamatergic dysfunction hypothesis suggests genes involved in glutamatergic transmission as candidates for schizophrenia susceptibility genes. We screened single nucleotide polymorphisms (SNPs) in the entire coding sequence of the GluR5 kainate receptor gene, GRIK1, by polymerase chain reaction-single strand conformation polymorphism and direct sequencing. We identified six SNPs including three known ones, 522A/C (174T, synonymous), 1173C/T (391D, synonymous), and 2705C/T (902L/S), as well as three novel ones, 995C/T (332A/V), 2400C/T (800L, synonymous), and 2585A/G (862R/Q). We genotyped Japanese samples of schizophrenia (n = 193-203) and healthy controls (n = 199-215) for three SNPs those were commonly observed in our samples, 522A/C, 1173C/T, and 2705C/T. We observed no significant associations of the SNPs and their haplotypes with schizophrenia. Therefore, we conclude that GRIK1 does not play a major role in schizophrenia pathogenesis in the Japanese population.


Sujet(s)
Polymorphisme de nucléotide simple , Récepteurs métabotropes au glutamate/génétique , Schizophrénie/génétique , Séquence nucléotidique , Amorces ADN , Fréquence d'allèle , Haplotypes , Hétérozygote , Homozygote , Humains , Réaction de polymérisation en chaîne , Récepteur-5 métabotropique du glutamate , Valeurs de référence
6.
Exp Cell Res ; 271(1): 161-8, 2001 Nov 15.
Article de Anglais | MEDLINE | ID: mdl-11697892

RÉSUMÉ

We previously identified HSPB2, a new member of the small heat shock protein family, expressed in heart and skeletal muscles. In this study, we used a polyclonal anti-HSPB2 antibody and examined the subcellular localization of HSPB2 in differentiated C2C12 cells, KNS-81 cells, and NIH3T3 transfectants expressing human HSPB2. Double staining with anti-HSPB2 and various markers for cytoplasmic structures showed that HSPB2 was present in the cytosol as granules, some of which colocalized with mitochondria. This colocalization was not altered by a colchicine treatment, indicating that it is independent of microtubules. The subcellular fractionation of differentiated C2C12 cells revealed that HSPB2 was mainly detected in the postmitochondrial supernatant, but mild heat treatment enriched the amount of HSPB2 in the mitochondrial fraction. The expression of HSPB2 protected the cells from heat-induced cell death. In addition, Northern blot analysis revealed that expression of HSPB2 mRNA is higher in slow-twitch muscle than in fast-twitch muscle, which correlates with the amounts of mitochondria present in these two types of tissue. Taken together, these results suggest that HSPB2 may not localize in the matrix, but rather associates with the outer membrane components of the mitochondria and thus plays a role in the stress response.


Sujet(s)
Protéines du choc thermique/métabolisme , Mitochondries/physiologie , Animaux , Différenciation cellulaire , Fractionnement cellulaire , Lignée cellulaire , Cristallines/génétique , Cristallines/métabolisme , Protéines du choc thermique HSP27 , Protéines du choc thermique/génétique , Réaction de choc thermique , Humains , Immunohistochimie , Fibres musculaires à contraction rapide/métabolisme , Fibres musculaires à contraction lente/métabolisme , Muscles squelettiques/physiologie , Protéines de fusion recombinantes/génétique , Protéines de fusion recombinantes/métabolisme , Transfection
7.
J Biochem ; 129(5): 813-20, 2001 May.
Article de Anglais | MEDLINE | ID: mdl-11328606

RÉSUMÉ

alphaB-Crystallin, a member of the small heat shock protein (HSP) family, accumulates in reactive astrocytes in a variety of pathological conditions. We previously reported the upregulation of alphaB-crystallin in response to high extracellular potassium concentration. In the present study, we investigated the regulatory mechanism of alphaB-crystallin expression by KCl. When human glioma U-251MG cells were exposed to continuous KCl treatment, induction of alphaB-crystallin mRNA was observed after 8 h and persisted for a few days. Functional promoter analysis using deletion and mutation constructs revealed that the proximal heat shock element (HSE-P), which contributes to heat shock induction in HeLa cells, is essential for transcriptional activation of the alphaB-crystallin gene by KCl in U-251MG cells. Gel mobility shift and antibody supershift assays showed that KCl induces the HSE-binding activity of heat shock factor (HSF) 2, while heat shock induces that of HSF1. This is the first demonstration that HSF2 can be activated by KCl and is involved in the upregulation of alphaB-crystallin gene expression in glial cells.


Sujet(s)
Cristallines/agonistes , Cristallines/génétique , Protéines de liaison à l'ADN/métabolisme , Troubles dus à la chaleur/métabolisme , Protéines du choc thermique/métabolisme , Chlorure de potassium/pharmacologie , Facteurs de transcription/métabolisme , Sites de fixation/effets des médicaments et des substances chimiques , Cristallines/biosynthèse , Protéines de liaison à l'ADN/composition chimique , Protéines de liaison à l'ADN/effets des médicaments et des substances chimiques , Régulation de l'expression des gènes/effets des médicaments et des substances chimiques , Régulation de l'expression des gènes/génétique , Gliome/métabolisme , Cellules HeLa/métabolisme , Facteurs de transcription de choc thermique , Protéines du choc thermique/composition chimique , Protéines du choc thermique/effets des médicaments et des substances chimiques , Humains , Chlorure de potassium/métabolisme , Régions promotrices (génétique)/effets des médicaments et des substances chimiques , Régions promotrices (génétique)/génétique , ARN messager/agonistes , ARN messager/génétique , Facteurs de transcription/composition chimique , Facteurs de transcription/effets des médicaments et des substances chimiques , Activation de la transcription/effets des médicaments et des substances chimiques , Activation de la transcription/génétique , Cellules cancéreuses en culture/métabolisme , Régulation positive
8.
J Hum Genet ; 46(1): 26-31, 2001.
Article de Anglais | MEDLINE | ID: mdl-11289715

RÉSUMÉ

The human dopamine D4 receptor (DRD4) is of major interest in molccular studies of schizophrenia and personality traits. We examined the association of schizophrenia and polymorphisms in the upstream region of the DRD4 gene (-768G>A in the negative modulator region; -521C>T, -376C >T, and -291C>T in the cell type-specific promoter region; and -616C>G between the two regions) in 208 schizophrenic patients and 210 normal controls. No significant difference in genotype and allele frequencies was observed between the two groups, indicating that these polymorphisms do not make a major contribution to the pathogenesis of schizophrenia. We also studied the association of polymorphisms in the upstream region and a 48-bp repeat polymorphism in exon III of the DRD4 gene with personality traits in 173 Japanese individuals who completed the temperament and character inventory (TCI). The -768G>A polymorphism was significantly associated with reward dependence (P= 0.044), while no significant association was observed between novelty seeking and polymorphisms in the upstream region or the exon III repeat polymorphism of the DRD4 gene.


Sujet(s)
Personnalité/génétique , Polymorphisme génétique , Récepteur D2 de la dopamine/génétique , Schizophrénie/génétique , Séquence nucléotidique , Amorces ADN , Humains , Déséquilibre de liaison , Récepteur D4 de la dopamine
9.
Mol Psychiatry ; 6(2): 186-92, 2001 Mar.
Article de Anglais | MEDLINE | ID: mdl-11317221

RÉSUMÉ

Metabotropic glutamate receptors (mGluRs) belong to the class of GTP-binding protein coupled receptors and consist of eight different subtypes. The subtype 2 metabotropic glutamate receptor (mGluR2) gene (GRM2) is one of the possible candidate genes for schizophrenia. Phencyclidine (PCP)-induced increase in glutamate efflux and schizophrenia-like behavioral abnormalities were reduced by pretreatment of the mGluRII agonist LY354740 in rats and its effects are mediated via mGluR2. To evaluate involvement of the mGluR2 gene in the pathogenesis of schizophrenia, we isolated the human mGluR2 gene and determined the transcription initiation site, the entire nucleotide sequence and the chromosomal localization. The hmGluR2 gene spans 13 kb with six exons, including one non-coding exon. The gene was mapped to chromosome 3 p12-p11 by Radiation Hybrid Panel analysis. We screened polymorphisms in the coding exons of the mGluR2 gene, using the SSCP procedure. The thirteen polymorphisms identified included ten missense, one silent mutation and two one-base substitutions in the 5'-untranslated region. We genotyped 213 Japanese schizophrenics and 220 controls to study the association of polymorphisms in the mGluR2 gene with schizophrenia. As we found no statistically significant differences in allele frequencies of each polymorphism, these polymorphisms apparently do not play a major role in schizophrenia.


Sujet(s)
Chromosomes humains de la paire 3 , Polymorphisme de conformation simple brin , Récepteurs métabotropes au glutamate/génétique , Schizophrénie/génétique , Chimie du cerveau/génétique , Études cas-témoins , Cartographie chromosomique , Amorces ADN , ADN complémentaire , Exons , Femelle , Humains , Mâle , Adulte d'âge moyen , Sites d'épissage d'ARN/génétique
10.
Blood ; 97(5): 1172-9, 2001 Mar 01.
Article de Anglais | MEDLINE | ID: mdl-11222358

RÉSUMÉ

Aberrant hypermethylation of tumor suppressor genes plays an important role in the development of many tumors. Recently identified new DNA methyltransferase (DNMT) genes, DNMT3A and DNMT3B, code for de novo methyltransferases. To determine the roles of DNMT3A, DNMT3B, as well as DNMT1, in the development of leukemia, competitive polymerase chain reaction (PCR) assays were performed and the expression levels of DNMTs were measured in normal hematopoiesis, 33 cases of acute myelogenous leukemia (AML), and 17 cases of chronic myelogenous leukemia (CML). All genes were constitutively expressed, although at different levels, in T lymphocytes, monocytes, neutrophils, and normal bone marrow cells. Interestingly, DNMT3B was expressed at high levels in CD34(+) bone marrow cells but down-regulated in differentiated cells. In AML, 5.3-, 4.4-, and 11.7-fold mean increases were seen in the levels of DNMT1, 3A, and 3B, respectively, compared with the control bone marrow cells. Although CML cells in the chronic phase did not show significant changes, cells in the acute phase showed 3.2-, 4.5-, and 3.4-fold mean increases in the levels of DNMT1, 3A, and 3B, respectively. Using methylation-specific PCR, it was observed that the p15(INAK4B) gene, a cell cycle regulator, was methylated in 24 of 33 (72%) cases of AML. Furthermore, AML cells with methylated p15(INAK4B) tended to express higher levels of DNMT1 and 3B. In conclusion, DNMTs were substantially overexpressed in leukemia cells in a leukemia type- and stage-specific manner. Up-regulated DNMTs may contribute to the pathogenesis of leukemia by inducing aberrant regional hypermethylation. (Blood. 2001;97:1172-1179)


Sujet(s)
Protéines du cycle cellulaire , Inhibiteur p16 de kinase cycline-dépendante , DNA (cytosine-5-)-methyltransferase/métabolisme , Hématopoïèse/génétique , Leucémie myéloïde chronique BCR-ABL positive/enzymologie , Protéines suppresseurs de tumeurs , Maladie aigüe , Protéines de transport/génétique , Inhibiteur p15 de kinase cycline-dépendante , DNA (Cytosine-5-)-methyltransferase 1 , DNA (cytosine-5-)-methyltransferase/génétique , DNA (cytosine-5-)-methyltransferase/physiologie , Méthylation de l'ADN , DNA methyltransferase 3A , ADN tumoral/génétique , Gènes suppresseurs de tumeur , Humains , Leucémie myéloïde chronique BCR-ABL positive/étiologie , Leucémie myéloïde chronique BCR-ABL positive/génétique , Réaction de polymérisation en chaîne , Transfection , Cellules cancéreuses en culture ,
11.
Jpn J Physiol ; 50(3): 329-36, 2000 Jun.
Article de Anglais | MEDLINE | ID: mdl-11016983

RÉSUMÉ

Murine erythroleukemia (MEL) cells were exposed to a high pressure of 80 MPa or aphidicolin (APH), DNA polymerase inhibitor. The effects of caffeine on cell cycle were examined using these cells. During the culture of 80 MPa-treated MEL cells at atmospheric pressure, the cells arrested in the G2 phase, and cyclin B and hyperphosphorylated p34(cdc2) were accumulated. Namely, maturation promoting factor (MPF) composed of p34(cdc2) and cyclin B was inactive. However, upon exposure to caffeine, these cells entered prematurely into mitosis by activating MPF. Caffeine-induced premature mitosis was suppressed by butyrolactone I and orthovanadate. On the other hand, APH-treated MEL cells, which were not exposed to 80 MPa, were not so sensitive to caffeine-induced premature mitosis despite cyclin B accumulation. In this case, dephosphorylation of p34(cdc2) was not induced by caffeine. Interestingly, caffeine-induced premature mitosis in the 80 MPa-treated cells was also suppressed by APH. These results suggest that the premature mitosis of 80 MPa-treated MEL cells by caffeine is induced by active MPF, and that APH-sensitive molecules such as DNA polymerase may also play an important role in the checkpoint that controls the transition from G2 to M phase.


Sujet(s)
Pression atmosphérique , Caféine/pharmacologie , Leucémie érythroblastique aigüe , Mitose/effets des médicaments et des substances chimiques , Inhibiteurs de la phosphodiestérase/pharmacologie , Animaux , Aphidicoline/pharmacologie , DNA-directed DNA polymerase/métabolisme , Antienzymes/pharmacologie , Phase G1/effets des médicaments et des substances chimiques , Phase G1/physiologie , Phase G2/effets des médicaments et des substances chimiques , Phase G2/physiologie , Mitose/physiologie , Phase S/effets des médicaments et des substances chimiques , Phase S/physiologie , Cellules cancéreuses en culture/cytologie , Cellules cancéreuses en culture/effets des médicaments et des substances chimiques , Cellules cancéreuses en culture/enzymologie
12.
Int J Hematol ; 72(1): 28-33, 2000 Jul.
Article de Anglais | MEDLINE | ID: mdl-10979205

RÉSUMÉ

Hemoglobin (Hb) E is the most common Hb variant among Southeast Asian populations. The mutation in codon 26 (GAG to AAG) of the beta-globin gene (beta E) induces alternative splicing, resulting in the production of normally and aberrantly spliced beta-globin mRNA. Compound heterozygosity for beta-thalassemia and HbE, beta-thalassemia/HbE disease, could lead to a severe thalassemia phenotype. Repression of aberrant splicing from the beta E mutation could ameliorate the severity in such patients. We showed that the aberrant splicing was partially repressed in cells treated with antisense oligoribonucleotide targeted to the aberrant 5' splice site. The maximum effect of the antisense oligoribonucleotide was observed at a concentration of 0.4 mumol/L, 36 hours after the treatment in our experiment. We also analyzed the effect of the transient and stable expression of SF2/ASF on aberrant splicing in cells expressing the beta E-globin gene. Partial repression of the aberrant splicing was also observed in both expression systems. Our results imply that antisense oligoribonucleotide treatment and SF2/ASF expression are possible therapeutic applications for beta-thalassemia/HbE disease.


Sujet(s)
Globines/génétique , Hémoglobine E/génétique , Protéines nucléaires/pharmacologie , Oligoribonucléotides antisens/pharmacologie , Épissage des ARN/effets des médicaments et des substances chimiques , Cellules HeLa , Hémoglobinurie/génétique , Hémoglobinurie/thérapie , Humains , Protéines nucléaires/génétique , Protéines nucléaires/usage thérapeutique , Oligoribonucléotides antisens/génétique , Oligoribonucléotides antisens/usage thérapeutique , Épissage des ARN/génétique , Protéines de liaison à l'ARN , Facteurs d'épissage riches en sérine-arginine , Transfection
13.
J Hum Genet ; 45(3): 127-32, 2000.
Article de Anglais | MEDLINE | ID: mdl-10807536

RÉSUMÉ

Thalassemia is a prevalent hereditary disorder characterized by impaired synthesis of globin chains. It has been suggested that the high frequency of thalassemia might reflect heterozygote advantage due to reduced susceptibility to malaria. In Nepal, malaria has often occurred in places below the altitude of 1,200m. We carried out a microepidemiological study on thalassemia in two neighboring populations in Nepal, the Danuwar and the Tamang. Settlements of the Danuwar are located below the limit of the malarial zone (1,200m in altitude), whereas those of the Tamang are found in malaria-free uplands. Three heterozygotes for hemoglobin E (HbE) were observed in the Danuwars. We detected one type (-alpha3.71) of alpha+-thalassemia that involves a deletion of 3.7kb, leading to a loss of one of two alpha-globin genes, in the Danuwars, at a high gene frequency of 63%, while the gene frequency in the Tamangs was only 5%. Analysis of the alpha-globin gene cluster revealed that four different haplotypes were associated with the type of alpha+-thalassemia in the Danuwars. Nucleotide sequences of the D-loop region in the mitochondrial DNA of the two populations indicated a similar nucleotide diversity in each population. The fixation index, FST, representing the degree of genetic differentiation estimated from mitochondrial DNA diversities (FST, 0.05), was smaller than that obtained from the gene frequencies of alpha-thalassemia (FST, 0.55). If we assume neutral molecular evolution in the D-loop region of mitochondrial DNA, these results suggest that the high frequency of alpha+-thalassemia may be due to biological adaptation to the malarial environment rather than to events such as a bottleneck.


Sujet(s)
Paludisme/épidémiologie , Paludisme/génétique , alpha-Thalassémie/génétique , ADN mitochondrial/génétique , Fréquence d'allèle , Variation génétique , Haplotypes , Hémoglobine E/génétique , Hétérozygote , Humains , Inde , Paludisme/sang , Mutation , Topographie médicale , alpha-Thalassémie/sang
14.
Biochem J ; 347(Pt 2): 491-9, 2000 Apr 15.
Article de Anglais | MEDLINE | ID: mdl-10749679

RÉSUMÉ

Conventional chromatographic analysis showed that phospholipase A(2) (PLA(2)) isoenzymes of the venom of Trimeresurus flavoviridis (Habu snake) of Okinawa island are profoundly different in composition from those of T. flavoviridis of Amami-Oshima and Tokunoshima islands. The most striking feature was that myotoxic [Lys(49)]PLA(2) isoenzymes, called BPI and BPII, which are expressed abundantly in the venoms of Amami-Oshima and Tokunoshima T. flavoviridis, are missing from the venom of Okinawa T. flavoviridis. Northern blot analysis of Okinawa T. flavoviridis venom-gland mRNA species showed the absence of BPI and BPII mRNA species. Analysis by single-stranded conformational polymorphism-PCR of venom-gland mRNA species of T. flavoviridis from three islands, with reference to five DNA species each encoding different PLA(2) isoenzymes from Tokunoshima T. flavoviridis venom gland, also suggested that BPI and BPII mRNA species are not expressed in Okinawa T. flavoviridis venom gland. In contrast, genomic Southern blot analysis with a variety of probes showed that only the bands corresponding to the upstream and downstream regions of the genes for BPI and/or BPII can be detected in Okinawa T. flavoviridis. These results suggested that the genes for BPI and BPII in Okinawa T. flavoviridis genome had been inactivated to form pseudogenes. Differently from Amami-Oshima and Tokunoshima T. flavovirdis genomic DNAs, PCR amplification of the segments of BPI and BPII genes between the 5' moiety of second exon and the middle portion of second intron failed for Okinawa T. flavoviridis genomic DNAs. In sequence analysis of the two segments involving polymorphism between BPI and BPII genes, which are located in first exon and third exon, respectively, only one base was detected at the polymorphic positions for pseudogene in Okinawa T. flavoviridis genome. Based on these facts, it became evident for pseudogene that the upstream region of BPI gene down to the 5' moiety of second exon and the downstream region of BPII gene starting from the middle portion of second intron are in a linked form with a possible insertion. Such observations suggest that venom-gland genes for PLA(2) isoenzymes in T. flavoviridis snakes isolated for one to two million years have evolved independently. Their evolution is regional and seems, from several lines of consideration and observation, to be adaptive to the environment.


Sujet(s)
Venins de crotalidé/enzymologie , Venins de crotalidé/génétique , Évolution moléculaire , Phospholipases A/génétique , Trimeresurus/génétique , Animaux , Technique de Southern , Dosage génique , Isoenzymes/génétique , Isoenzymes/isolement et purification , Japon , Modèles génétiques , Phospholipases A/isolement et purification , Phospholipases A2 , Polymorphisme de conformation simple brin , Pseudogènes/génétique , ARN messager/analyse , ARN messager/génétique , RT-PCR , Analyse de séquence d'ADN
16.
Toxicon ; 38(3): 449-62, 2000 Mar.
Article de Anglais | MEDLINE | ID: mdl-10669032

RÉSUMÉ

In accordance with detection of a few phospholipase A2 (PLA2) isozyme genes by Southern blot analysis, only two cDNAs, named NnkPLA-I , and NnkPLA-II, encoding group I PLA2s, NnkPLA-I and NnkPLA-II, respectively, were isolated from the venom gland cDNA library of Elapinae Naja naja kaouthia of Malaysia. NnkPLA-I and NnkPLA-II showed four amino acid substitutions, all of which were brought about by single nucleotide substitution. No existence of clones encoding CM-II and CM-III, PLA2 isozymes which had been isolated from the venom of N. naja kaouthia of Thailand, in Malaysian N. naja kaouthia venom gland cDNA library was verified by dot blot hybridization analysis with particular probes. NnkPLA-I and NnkPLA-II differed from CM-II and CM-III with four and two amino acid substitutions, respectively, suggesting that their molecular evolution is regional. The comparison of NnkPLA-I, NnkPLA-II and cDNAs encoding other group I snake venom gland PLA2s indicated that the 5'- and 3'-untranslated regions are more conserved than the mature protein-coding region and that the number of nucleotide substitutions per nonsynonymous site is almost equal to that per synonymous site in the protein-coding region, suggesting that accelerated evolution has occurred in group I venom gland PLA2s possibly to acquire new physiological functions.


Sujet(s)
Évolution moléculaire , Glandes exocrines/composition chimique , Phospholipases A/composition chimique , Venins de serpent/composition chimique , Séquence d'acides aminés , Technique de Southern , Clonage moléculaire , Fragmentation de l'ADN , Banque de gènes , Immunotransfert , Hybridation in situ , Isoenzymes/composition chimique , Isoenzymes/génétique , Données de séquences moléculaires , Phospholipases A/génétique , Phospholipases A2 , Venins de serpent/génétique
17.
J Hum Genet ; 44(6): 416-8, 1999.
Article de Anglais | MEDLINE | ID: mdl-10570917

RÉSUMÉ

We found nine novel polymorphisms in the upstream region of the human dopamine D4 receptor (DRD4) gene of Japanese by direct sequencing. These polymorphisms are -809G > A, -768G > A, -616C > G, -603T > del, -602G > del, -600G > C, -376C > T, -291C > T, and -128G > T. One known polymorphism, -521C > T, was also recognized. Six of these sites were identified as restriction fragment length polymorphisms (RFLPs).


Sujet(s)
Polymorphisme génétique/génétique , Régions promotrices (génétique)/génétique , Récepteur D2 de la dopamine/génétique , Humains , Récepteur D4 de la dopamine
18.
Am J Hematol ; 61(1): 1-4, 1999 May.
Article de Anglais | MEDLINE | ID: mdl-10331503

RÉSUMÉ

We identified and characterized a novel beta(0)-thalassemia mutation due to partial deletion of the 5' end beta-globin gene including the mRNA cap site and a part of exon 1. The deletion was precisely 105 basepair (bp) in length extending from position -24 or -25 to +80 or +81 relative to the beta-globin gene mRNA cap site. This mutation was detected in three individuals from a family originating in the area of southern Thailand. The propositus was a 39-year-old female and noted to be heterozygous for beta-thalassemia with hemoglobin (Hb) level of 10.1 g/dl, MCV 70 fl, MCH 23.1 pg, HbA2 6.3%, and HbF 2.4%. Her son was 9 years of age and was also heterozygous for the mutation, having Hb level of 10.8 g/dl, MCV 58 fl, MCH 19.0 pg, HbA2 5.6%, and HbF 4.3%. Her 6-year-old daughter was affected, having a genotype of this mutation and a G-C transition at IVS 1 nt 5. Although the deletion does not include the beta-globin gene promoter sequences, the individuals heterozygous for this mutation have an elevated HbA2 level slightly higher than observed in most carriers of beta-thalassemia caused by point mutations.


Sujet(s)
Appariement de bases , Délétion de gène , bêta-Thalassémie/génétique , Adulte , Séquence nucléotidique , Enfant , ADN/analyse , ADN/composition chimique , Index érythrocytaires , Exons , Femelle , Hémoglobine foetale/analyse , Globines/génétique , Hémoglobine A2/analyse , Hétérozygote , Humains , Mâle , Coiffes des ARN/génétique , ARN messager/génétique , Thaïlande
19.
J Hum Genet ; 44(3): 152-62, 1999.
Article de Anglais | MEDLINE | ID: mdl-10319578

RÉSUMÉ

The position-independent expression of transgenes in target cells is an essential subject for determining effective gene therapies. The chicken beta-globin insulator blocks the effects of regulatory sequences on transcriptional units at differential domains. We prepared a recombinant adeno-associated virus (rAAV) containing various combinations of the DNase I-hypersensitive site 2 (HS2), 3 (HS3), and 4 (HS4) core elements from the human beta-globin locus control region (LCR), the human beta-globin gene, and the herpes virus thymidine kinase promoter driven neomycin-resistant gene (neoR) (rHS432, rHS43, rHS42, rHS32, and rHS2), and also rAAV containing two copies of the 250-bp core sequence of the chicken beta-globin insulator on both sides of the rHS2 (rIns/HS2/2Ins). After isolating neomycin-resistant mouse erythroleukemia (MEL) cells infected with each rAAV, we analyzed the rAAV genome by Southern blots and polymerase chain reaction (PCR), using primers specific for HS core elements and the human beta-globin gene. All clones contained a single copy of the rAAV genome in the chromosome, however, some of them had a rearranged proviral genome. In five clones with a single unrearranged rAAV genome for each rAAV construct, we assayed the expression of the human b-globin gene relative to the endogenous mouse beta maj-globin gene, using quantitative reverse transcriptase (RT)-PCR. In clones infected with rHS432, the expression level of the human beta-globin gene ranged from 51.6% to 765.6% of that in the mouse beta maj-globin gene. Likewise, in rHS43, the expression level ranged from 36.7% to 259.0%; in rHS42, from 47.8% to 207.0%; in rHS32, from 47.9% to 105.4%; and in rHS2, from 6.1% to 172.1%, indicating a high variability of expression level in clones infected with recombinant virus lacking the insulator. In contrast, in clones infected with rIns/HS2/Ins, the range of expression of the human beta-globin gene ranged from 52.8% to 58.3% of that in the mouse beta maj-globin gene. These results indicate that the insulator functioned dramatically to reduce the variability of transgene expression due to the position effect. This insulator-rAAV vector system holds promise to provide a constant level of transgene expression for gene therapy, regardless of the insertion sites on the chromosome.


Sujet(s)
Dependovirus/génétique , Vecteurs génétiques , Globines/biosynthèse , Globines/génétique , Animaux , Poulets , Expression des gènes , Thérapie génétique/méthodes , Cellules HeLa , Humains , Leucémie érythroblastique aigüe , Souris , Famille multigénique , Séquences d'acides nucléiques régulatrices , Thalassémie/thérapie , Transformation génétique , Cellules cancéreuses en culture
20.
Brain Res Mol Brain Res ; 64(1): 119-31, 1999 Jan 22.
Article de Anglais | MEDLINE | ID: mdl-9889345

RÉSUMÉ

The effects of repeated methamphetamine administration on c-fos mRNA and aldolase C (Zebrin) mRNA expression in the rat cerebellum were investigated. A single dose of methamphetamine induced c-fos mRNA expression in granule and Purkinje cells of both anterior and posterior lobes. In the posterior lobe, in particular, c-fos mRNA signals were distributed in a parasagittal organization, like Zebrin bands. Repeated methamphetamine injections reduced methamphetamine-induced c-fos mRNA signals in the anterior hemisphere and in part of the posterior vermis (lobule VII) and posterior hemisphere. Aldolase C mRNA signals in Purkinje cells decreased only in lobules where methamphetamine-induced c-fos signals were not reduced (lobules VI and IX). Therefore, differential decreases in c-fos mRNA and aldolase C mRNA expression after repeated methamphetamine administration depend upon the localization of Purkinje cells in the cerebellum. Since c-fos mRNA and aldolase C mRNA expressions are markers of excitability and the metabolic state of Purkinje cells, respectively, hypofunction of inhibitory Purkinje cells could be induced if methamphetamine is repeatedly injected. Since repeated methamphetamine administration in this experimental paradigm increased horizontal movement and the rearing activity of rats, the hemisphere of the cerebellum may be involved in development of methamphetamine-induced motor behavioral sensitization in addition to the striatum and the nucleus accumbens.


Sujet(s)
Cervelet/composition chimique , Agents dopaminergiques/pharmacologie , Fructose bisphosphate aldolase/génétique , Métamfétamine/pharmacologie , Protéines proto-oncogènes c-fos/génétique , Animaux , Technique de Northern , Cervelet/physiologie , Dopamine/physiologie , Régulation de l'expression des gènes codant pour des enzymes , Hybridation in situ , Mâle , ARN messager/métabolisme , Rats , Rat Sprague-Dawley , Schizophrénie/métabolisme
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...